These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2920505)

  • 1. Effects of time of dose in relation to food on the bioavailability of Theo-Dur Sprinkle at steady state in asthmatic children.
    Birkett DJ; Lines DR; Kneebone GM; Green B; Hughes HM
    Clin Pharmacol Ther; 1989 Mar; 45(3):305-11. PubMed ID: 2920505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bioavailability of slow-release theophylline from unencapsulated beads in preschool children with chronic asthma.
    Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Harris JB
    Ther Drug Monit; 1988; 10(4):395-400. PubMed ID: 3059587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma.
    Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG
    J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
    Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle.
    Karim A; Burns T; Wearley L; Streicher J; Palmer M
    Clin Pharmacol Ther; 1985 Jul; 38(1):77-83. PubMed ID: 4006379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.
    Coulthard KP; Birkett DJ; Lines DR; Grgurinovich N; Grygiel JJ
    Eur J Clin Pharmacol; 1983; 25(5):667-72. PubMed ID: 6686557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline pharmacokinetics in children, comparing sustained release spheres (Theo-Dur sprinkle) with elixir.
    Kjellman NI; Croner S; Leijon I; Friberg K; Thuresson SO
    Eur J Pediatr; 1988 Dec; 148(3):278-80. PubMed ID: 3215203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ; Cefali EA; Straughn AB
    Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
    Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
    Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
    Rogers RJ; Wiener MB; Hill MR; Szefler SJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1168-73. PubMed ID: 3674579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of a new sustained-release theophylline capsule in fasted and non-fasted healthy subjects: single and multiple dosing studies.
    West RJ; Boehm G; Dwyer M; Williams DB; Sansom LN; Penna AC
    Biopharm Drug Dispos; 1990 Mar; 11(2):165-77. PubMed ID: 2328301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained-release theophylline for treatment of asthma in preschool children.
    Simons FE; Luciuk GH; Simons KJ
    Am J Dis Child; 1982 Sep; 136(9):790-3. PubMed ID: 7114002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence of a generic slow-release theophylline tablet in children.
    Kanthawatana S; Ahrens RC; McCubbin M; Bronsky E; Blake K; Hendeles L
    J Pediatr; 1994 Dec; 125(6 Pt 1):987-91. PubMed ID: 7996375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline absorption from sustained-release products: comparative steady-state bioavailability of once-daily Theo-Dur, Theo-24, and Uniphyl.
    Hurwitz A; Karim A; Burns TS
    J Clin Pharmacol; 1987 Nov; 27(11):855-61. PubMed ID: 3429692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption of Theo-Dur Sprinkle with food: importance of types of meals and medication times.
    Pedersen S
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 1):653-60. PubMed ID: 3771955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food and fasting absorption of a single dose of a sustained release theophylline sprinkle formulation in children.
    Pedersen S; Steffensen G
    Allergy; 1986 Jan; 41(1):46-50. PubMed ID: 3963315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state evaluation of twice-a-day dosing of a new sustained-release theophylline preparation for young children.
    Welch MJ; Kemp JP; Orgel HA; Meltzer EO
    J Asthma; 1985; 22(5):249-52. PubMed ID: 4055657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratic absorption of a slow-release theophylline sprinkle product.
    Pedersen S; Møller-Petersen J
    Pediatrics; 1984 Oct; 74(4):534-8. PubMed ID: 6483520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.